ANP Technologies

ANP Technologies is a private Delaware-based company specializing in advanced nano-detection platforms for biothreats and chemical agents. With a foundation dating back to 2002, the company has leveraged its expertise in nanotechnology and immunoassays to create rapid, sensitive, and portable diagnostic systems. Its primary market includes government defense and homeland security agencies, with applications expanding into food safety and clinical diagnostics. The company's value proposition centers on providing critical situational awareness in minutes, a significant advantage over traditional lab-based methods.

Nano-Intelligent Detection System (NIDS®) platform utilizing fluorescent nanocrystal labels and monoclonal antibodies in a lateral flow format for rapid, sensitive, multiplexed detection of biological and chemical threats.

ANP competes in a specialized segment against large defense contractors (e.g., Teledyne FLIR, Bruker) with broader CBRNe portfolios and established government relationships. It also faces competition from other biotechnology firms developing rapid POC diagnostics, as well as emerging technologies like CRISPR-based detection and next-generation sequencing platforms.